PARNASSUS INVESTMENTS, LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
1 Market Street #1600 San Francisco, CA 94105
As of the latest 13F report, the guru’s equity portfolio contained 136 stocks valued at a total of $40.25Bil. The top holdings were
According to GuruFocus data, these were PARNASSUS INVESTMENTS, LLC’s top five trades of the quarter.
Oracle Corp
The guru established a new position worth 11,936,640 shares in NYSE:ORCL, giving the stock a 1.9% weight in the equity portfolio. Shares traded for an average price of $73.20999999999999 during the quarter.
On 01/30/2023, Oracle Corp traded for a price of $87.19499999999999 per share and a market cap of $235.10Bil. The stock has returned 9.97% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Oracle Corp has a price-earnings ratio of 27.33, a price-earnings-to-growth (PEG) ratio of 3.60, a EV-to-Ebitda ratio of 18.12 and a price-sales ratio of 5.18.
The price-to-GF Value ratio is 1.01, earning the stock a GF Value rank of 5.
Boston Scientific Corp
The guru sold out of their 15,691,959-share investment in NYSE:BSX. Previously, the stock had a 1.4% weight in the equity portfolio. Shares traded for an average price of $40.12 during the quarter.
On 01/30/2023, Boston Scientific Corp traded for a price of $45.68 per share and a market cap of $65.43Bil. The stock has returned 6.87% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, Boston Scientific Corp has a price-earnings ratio of 108.76, a price-book ratio of 3.71, a price-earnings-to-growth (PEG) ratio of 17.54, a EV-to-Ebitda ratio of 29.87 and a price-sales ratio of 5.22.
The price-to-GF Value ratio is 0.97, earning the stock a GF Value rank of 6.
Abbott Laboratories
The guru established a new position worth 4,973,587 shares in NYSE:ABT, giving the stock a 1.25% weight in the equity portfolio. Shares traded for an average price of $106.59 during the quarter.
On 01/30/2023, Abbott Laboratories traded for a price of $110.08 per share and a market cap of $191.93Bil. The stock has returned -10.70% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Abbott Laboratories has a price-earnings ratio of 28.15, a price-book ratio of 5.38, a price-earnings-to-growth (PEG) ratio of 1.29, a EV-to-Ebitda ratio of 16.91 and a price-sales ratio of 4.46.
The price-to-GF Value ratio is 0.84, earning the stock a GF Value rank of 9.
Alexandria Real Estate Equities Inc
PARNASSUS INVESTMENTS, LLC reduced their investment in NYSE:ARE by 3,356,204 shares. The trade had a 1.16% impact on the equity portfolio. During the quarter, the stock traded for an average price of $153.47.
On 01/30/2023, Alexandria Real Estate Equities Inc traded for a price of $158.005 per share and a market cap of $25.93Bil. The stock has returned -14.37% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Alexandria Real Estate Equities Inc has a price-earnings ratio of 48.03, a price-book ratio of 1.46, a price-earnings-to-growth (PEG) ratio of 2.78, a EV-to-Ebitda ratio of 20.41 and a price-sales ratio of 10.08.
The price-to-GF Value ratio is 1.02, earning the stock a GF Value rank of 5.
Nike Inc
The guru sold out of their 2,743,938-share investment in NYSE:NKE. Previously, the stock had a 0.67% weight in the equity portfolio. Shares traded for an average price of $107.65 during the quarter.
On 01/30/2023, Nike Inc traded for a price of $126.67 per share and a market cap of $196.41Bil. The stock has returned -12.35% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Nike Inc has a price-earnings ratio of 35.68, a price-book ratio of 12.86, a price-earnings-to-growth (PEG) ratio of 4.20, a EV-to-Ebitda ratio of 27.21 and a price-sales ratio of 4.08.
The price-to-GF Value ratio is 0.85, earning the stock a GF Value rank of 7.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
